Medication Assisted Treatment

Opioid Use Disorders and Overdoses have turned into a national health crisis, and more effective and life-saving public health responses are imperative to curb this growing epidemic. Medication-Assisted Treatment has a profound role in the battle of the OUD epidemic. It is important to learn how to maximize MATs like Vivitrol, Narcan, Naltrexone, etc. and their efficacy in the context of an all-encompassing treatment approach.

Dr. Mark Gold & Dr. Brian Fuerhlein Discuss Medication-Assisted Treatment in Opiate Use Disorder & Substance Use Disorder

Opioid use and addiction have quickly transformed into a national health crisis of epidemic proportions, and the epidemic demands innovative scientific strategies and interventions.

The United States is the world’s largest consumer of opioids. The non-medicinal use of and addiction to opioids, particularly prescription pain relievers, heroin, and synthetic opioids like fentanyl, have escalated into a national epidemic adversely affecting public health, social welfare, and economic progress.

Every day, more than 115 people in the United States die due to overdosing on opioids. In 2016, 42,249 Americans fatally overdosed on an opioid. Of the 20.5 million Americans 12 or older who had a substance use disorder in 2015, 2 million had a substance use disorder involving prescription pain relievers, and 591,000 had a substance use disorder involving heroin.

In addition to Medication-Assisted Treatment (MAT), office-based opioid treatments and ambulatory detoxification, timely identification and treatment of co-existing trauma, sexually transmitted diseases, infections, cardiovascular and other common psychological co-occurring disorders have to take its due position in recovery.

While we often focus on reducing overdose and reversing those overdoses that occur, many overdoses are patients with OUDs who are not in treatment. Medication Addiction Treatment like Buprenorphine, Suboxone, Naloxone, and opioid use disorder treatment programs are essential parts of our response to overdose initiatives.

Deaths from overdose are increasing during the COVID-19 crisis as EMTs, Emergency Rooms, and General Hospitals are inundated with COVID cases, and people with OUDs are staying away. 47,600 people died from drug overdoses involving opioids in 2017.

Naloxone or Narcan: Life-saving Wonder Drug 2020

Hospital Room with Bed Contributor: Mark S. Gold, M.D., Professor, Washington University School of Medicine – Department of Psychiatry Opioid Use Disorders and Opioid Overdose Epidemics Cries for help have been increasing since the coronavirus quarantine. EMTs have been busy with COVID 19, as have community emergency departments and general hospitals. The overdose-reversal support system (Naloxone and other MATs) that [...]
Read More

Improving Addiction Treatments by Rediscovering HYPERKATIFEIA

Teenage girl struggling with addiction Contributor: Mark S. Gold, M.D., Professor, Washington University School of Medicine – Department of Psychiatry Drug Use Changes The Brain Pleasure Systems Drug addiction is defined by self-administration, compulsive drug-seeking, drug-rationing, and loss of control [1]. Chronic use itself may be followed by anhedonia, the emergence of a profoundly painful and negative emotional state [2]. I [...]
Read More

HHS Releases $487 Million to Increase Access to Effective Opioid Treatment

Man working on his alcoholism during the holidays Last month, the U.S. Department of Health and Human Resources (HHS) issued an additional $487 million in adjunction to the first-year funding through its State Opioid Response (SOR) grant program. These awards to states and territories are a component of HHS’s Five-Point Opioid Strategy. The U.S. opioid epidemic In the late 1990s, increased prescription of [...]
Read More

Buprenorphine An Effective OUD Treatment: An Updated Overview

Young woman doctor providing OUD Treatment Dr. Mark Gold’s Research You Can Use Recently released and revised medication-assisted treatments (MAT) have been an important area of research to counter the present opioid epidemic. MATs have helped patients in their recovery. It is the administration of opioid agonists (methadone, buprenorphine, oxycodone), antagonists (naltrexone, naloxone), and combinations of the two (buprenorphine/naloxone). While shown [...]
Read More

Experts Encourage Moving Methadone to Primary Care Setting

Doctor thinking about moving Methadone to Primary Care Dr. Mark Gold’s Research You Can Use The devastating repercussions exerted by the opioid overdose epidemic plaguing the nation has been nothing short of crippling. Opioid overdoses presently claim an average of 115 lives a day. In an article published Wednesday in the New England Journal of Medicine, Jeffrey Samet, chief of general internal medicine [...]
Read More